Voshells

Trust · Credentials

Voshell’s Credentials and Compliance

The credentials, accreditations, and compliance posture that support every Voshell’s prescription, partnership, and patient relationship.

Compounding pharmacies operate under a layered set of state, federal, and independent accreditation standards. Voshell’s has built our compliance posture around independent verification, transparent state licensure, and the regulatory partnerships that signal clinical and operational integrity. The credentials below are what every patient, prescriber, hospital, telehealth platform, and corporate wellness team should expect of a 503a compounding partner.

Independent Accreditation

Voshell’s is independently accredited by [PCAB or alternative accreditation body — verify and insert]. Independent accreditation means our compounding standards have been reviewed and verified by an external body — not by self-certification. This is the gold standard for 503a compounding pharmacies.

Licensure

State Licensure

Voshell’s is licensed to compound and dispense medications in:

  • Maryland (home state — Baltimore-based since 1927)
  • Delaware
  • Pennsylvania
  • Virginia
  • Washington DC

Voshell’s does not compound or dispense medications outside these four jurisdictions. State licensure verification is available on request.

Maryland
Delaware
Pennsylvania
Virginia
Washington DC

DEA

registered for controlled substance compounding

FDA

registered as a 503a compounding pharmacy

CMS

medicare provider compliant where applicable

HIPAA-compliant

infrastructure for all patient and prescriber communications

Registrations

Federal Registrations

A dedicated team of compounding specialists committed to personalized patient care

Verification

Industry Verification

A dedicated team of compounding specialists committed to personalized patient care

LegitScript verified

the gold-standard verification for online pharmacy practice

PCCA member

Professional Compounders Centers of America

Medisca, Fagron, and Alliance

for Pharmacy Compounding partner

Other

Other industry memberships as listed on individual partner pages

Quality and Compliance

Quality and Compliance Posture

Voshell’s maintains a compliance-first posture across the most regulatory-sensitive areas of compounding:

  • GLP-1 lockdown — Voshell’s does not compound semaglutide, tirzepatide, or branded GLP-1 medications
  • Peptide therapy — prescriber-led framing aligned with the 2026 HHS regulatory guidance
  • Ivermectin compounded ONLY in dermatology and parasitic-infection contexts — never in viral or respiratory framing
  • Detox and chelation — lab-justified, prescriber-led, evidence-based — never marketed as cleanses or flushes
  • Off-label use disclosed clearly throughout patient-facing content
  • FDA disclaimer present on every pharma-content page

Every Voshell’s prescription is compounded to the same standards regardless of who you are or where you came from. Detailed credentialing documentation, capability statements, and compliance attestations are available on request to qualified partners.

For Patients

Every Voshell’s prescription is compounded to the same standards regardless of who you are or where you came from. The credentials above exist to give you and your healthcare provider confidence in the consistency, sterility, and integrity of the medication you receive.

Talk With a Voshell’s Pharmacist

For Prescribers, Hospitals, and Partnership Buyers

Detailed credentialing documentation, capability statements, and compliance attestations are available on request to qualified partners — telehealth platforms, hospital systems, government procurement, corporate wellness programs, and concierge medicine practices.

Request Credentialing Documentation